Camp4 Therapeutics Corp — Form SCHEDULE 13D/A
Filed August 5, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
5AM Ventures VI, L.P. filed an amended Schedule 13D/A on August 5, 2026, regarding its beneficial ownership stake in Camp4 Therapeutics Corp (market value ~$14.6M). The filing document itself contains no substantive details of what was amended, the ownership percentage held, share count, or dollar amounts involved—only header metadata and addresses.
Why this rating
Schedule 13D amendments are routine regulatory filings when ownership disclosures require updating. Without disclosed specifics (stake size, changes made), cannot assess material impact. No concrete business change indicated.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.